FDA approves first at-home therapy for thyroid eye disease The first at-home subcutaneous treatment for thyroid eye disease met its primary end point in 1 of 2 phase 3 trials. By Mouj Hijazi October 16, 2026 2 min MDSpire News Share Summary Takeaways Listen Insight Report Clinical Scorecard Quiz Poll